Latest Vaishali Pharma stock price
Vaishali Pharma P/E Ratio
VAISHALI • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
141.33
High Valuation
Very High - High growth expectations or significantly overvalued
Current Valuation Metrics
P/E Ratio
141.33
Current Price
₹8.48
EPS (TTM)
₹0.06
Exchange
NSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
57.32
Sector Median
35.38
Sector Rank
#11 of 89
Sector Percentile
12.4%
Earnings Breakdown (TTM)
TTM EPS
₹0.19
Sept 2025
₹0.09
Jun 2025
₹0.10
Key P/E Ratio Insights for Vaishali Pharma
- Stock appears overvalued with PE of 141.33, suggesting caution for new investments
- Trading at premium to sector average PE of 57.32
View the VAISHALI equity price for detailed stock performance.
Related Pages for Vaishali Pharma
Additional stock information and data for VAISHALI
Sector P/E Ratio Comparison
Comparing Vaishali Pharma with other companies in Healthcare sector
Sector Average
57.32
Sector Median
35.38
Lowest P/E
9.01
Highest P/E
515.32
Companies
89
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Fermenta Biotech | FERMENTA | 9.01 | ₹1,010 | Low |
| Natco Pharma | NATCOPHARM | 10.8 | ₹17,006 | Low |
| Mohini Health & Hygiene | MHHL | 11.84 | ₹69 | Low |
| Lincoln Pharmaceuticals | LINCOLN | 12.02 | ₹974 | Low |
| QMS Medical Allied Servi… | QMSMEDI | 12.82 | ₹177 | Low |
| Take Solutions | TAKE | 13.15 | ₹638 | Low |
| Venus Remedies | VENUSREM | 14.27 | ₹995 | Low |
| Royal Sense | ROYAL | 14.5 | ₹96 | Low |
| Bliss GVS Pharma | BLISSGVS | 16.62 | ₹1,973 | Moderate |
| RPG Life Sciences | RPGLIFE | 17.94 | ₹3,861 | Moderate |